Rioux KP - Search Results

1

Hepatic mucosal mast cell hyperplasia in rats with secondary biliary cirrhosis.

Rioux KP, Sharkey KA, Wallace JL, Swain MG. Rioux KP, et al. Hepatology. 1996 Apr;23(4):888-95. doi: 10.1002/hep.510230433. Hepatology. 1996. PMID: 8666346

2

Decreased orexigenic response to neuropeptide Y in rats with obstructive cholestasis.

Rioux KP, Le T, Swain MG. Rioux KP, et al. Am J Physiol Gastrointest Liver Physiol. 2001 Mar;280(3):G449-56. doi: 10.1152/ajpgi.2001.280.3.G449. Am J Physiol Gastrointest Liver Physiol. 2001. PMID: 11171627

3

Differential leptin responses to acute and chronic biliary obstruction in rats.

Rioux KP, Beck PL, Hoppin AG, Ezedi I, Kaplan L, Le T, Swain MG. Rioux KP, et al. J Hepatol. 2000 Jul;33(1):19-25. doi: 10.1016/s0168-8278(00)80154-3. J Hepatol. 2000. PMID: 10905581

4

Colonic and jejunal motor disturbances after colonic antigen challenge of sensitized rat.

Oliver MR, Tan DT, Kirk DR, Rioux KP, Scott RB. Oliver MR, et al. Among authors: rioux kp. Gastroenterology. 1997 Jun;112(6):1996-2005. doi: 10.1053/gast.1997.v112.pm9178692. Gastroenterology. 1997. PMID: 9178692

5

Long-term antigen challenge results in progressively diminished mucosal mast cell degranulation in rats.

Rioux KP, Wallace JL. Rioux KP, et al. Gastroenterology. 1996 Dec;111(6):1516-23. doi: 10.1016/s0016-5085(96)70013-6. Gastroenterology. 1996. PMID: 8942730

6

Mast cells do not contribute to nonsteroidal anti-inflammatory drug-induced gastric mucosal injury in rodents.

Rioux KP, Wallace JL. Rioux KP, et al. Aliment Pharmacol Ther. 1996 Apr;10(2):173-80. doi: 10.1046/j.1365-2036.1996.724116000.x. Aliment Pharmacol Ther. 1996. PMID: 8730246

7

Mast cell activation augments gastric mucosal injury through a leukotriene-dependent mechanism.

Rioux KP, Wallace JL. Rioux KP, et al. Am J Physiol. 1994 May;266(5 Pt 1):G863-9. doi: 10.1152/ajpgi.1994.266.5.G863. Am J Physiol. 1994. PMID: 8203531

8

VSL#3 ® probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis.

Jayakumar S, Carbonneau M, Hotte N, Befus AD, St Laurent C, Owen R, McCarthy M, Madsen K, Bailey RJ, Ma M, Bain V, Rioux K, Tandon P. Jayakumar S, et al. Liver Int. 2013 Nov;33(10):1470-7. doi: 10.1111/liv.12280. Epub 2013 Aug 23. Liver Int. 2013. PMID: 23968203 Clinical Trial.

9

Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease.

Reid DT, McDonald B, Khalid T, Vo T, Schenck LP, Surette MG, Beck PL, Reimer RA, Probert CS, Rioux KP, Eksteen B. Reid DT, et al. Among authors: rioux kp. Biochim Biophys Acta. 2016 Jul;1862(7):1337-44. doi: 10.1016/j.bbadis.2016.04.005. Epub 2016 Apr 13. Biochim Biophys Acta. 2016. PMID: 27085070 Free article.

10

Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.

Lambert JE, Parnell JA, Eksteen B, Raman M, Bomhof MR, Rioux KP, Madsen KL, Reimer RA. Lambert JE, et al. Among authors: rioux kp. BMC Gastroenterol. 2015 Dec 3;15:169. doi: 10.1186/s12876-015-0400-5. BMC Gastroenterol. 2015. PMID: 26635079 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results